Piotr Jankowski
Public Health and Governance, Volume 13, Issue 4, 2015, pp. 328 - 336
https://doi.org/10.4467/20842627OZ.15.034.5461
Polish Cardiac Society recommends to use SCORE tables to estimate the risk of cardiovascular disease (CVD) in clinical practice.
The aim of the study was (1) to compare the estimates of the risk of death from cardiovascular disease (CVD) obtained by using a SCORE function calibrated for the Polish population in 2007 with the risk calculated from the observed number of CVD deaths in the last decade, and (2) to compare the estimates of the risk of death from CVD obtained by using a SCORE function calibrated for the Polish population in 2015 with the CVD risk estimated from the observed number of deaths in 2012, using data on the prevalence of risk factors from the two studies of the representative samples of Polish adult population (WOBASZ and WOBASZ 2).
The risk identified by the SCORE 2007 function was higher than the observed risk by 20–40% in men and 18–33% in women. This indicated that the SCORE 2007 function overestimated cardiovascular risk. The risk calculated by using the SCORE 2015 function was more similar to the CVD risk estimated by using the current mortality data. However, SCORE 2015 function may overestimate CVD risk in future if the decreasing mortality trend would persist in Poland.
Piotr Jankowski
Public Health and Governance, Volume 7, Issue 2, 2009, pp. 44 - 48
Background: Smoking is one of the most important risk factors. Persisting smoking after an coronary event is related to significantly higher risk of the future cardiovascular complications. Studies performed in late nineties showed that a considerable percentage of patients continue with smoking after an coronary event. The aim of the present paper was to compare smoking rates in coronary patients in the post-discharge period in Krakow in 1997/1998, 1999/2000 and 2006/2007.
Methods: Consecutive patients hospitalized from July 1, 1996 to September 31, 1997 (first survey), from March 1, 1998 to March 30, 1999 (second survey), and from April 1, 2005 to July 31, 2006 (third survey) due to acute myocardial infarction, unstable angina or for myocardial revascularization procedures, below the age of < 71 years were identified and then followed up, interviewed and examined 6–18 months after discharge. Self-reported smoking and breath carbon monoxide was analysed.
Results: The number of patients who participated in the follow-up examinations were: 418 (78.0%) in the first survey, 427 (82.9%) in the second and 427 (79.1%) in the third survey. There was no significant change in smoking (self-reported) rates (16% vs 16% vs 19%; p = NS). When breath carbon monoxide was also analysed once again the difference did not reach significance (18% in 1999–2000 and 23% in 2006–2007; p = NS). Nicotine replacement therapy, bupropion or varenicline were also not used (0% vs 0.2% vs 0.5%; p = NS).
Conclusion: The smoking rate in coronary patients over the decade from 1997/1998 to 2006/2007 did not changed significantly. The pharmacotherapy for smoking is almost not used in coronary patients.